Organ donor specimens: What can they tell us about type 1 diabetes?

Pediatric Diabetes

Volumn 16, Issue 5, 2015, Pages 320-330

  Campbell Thompson, Martha ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Beta cell; Image analysis; Insulin; Insulitis; Islet

Indexed keywords

AUTOANTIBODY; INSULIN;

CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DISEASE DURATION; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HISTOPATHOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; ORGAN SIZE; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TISSUE DISTRIBUTION; TISSUE PRESERVATION; UNITED STATES; WEIGHT REDUCTION; CELL COUNT; DIABETES MELLITUS, TYPE 1; DONOR; IMMUNOLOGY; MEDICAL RESEARCH; METABOLISM; PATHOLOGY;

AUTOANTIBODIES; BIOMEDICAL RESEARCH; CELL COUNT; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; INSULIN-SECRETING CELLS; PANCREAS; TISSUE DONORS;

EID: 84936219333     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12286     Document Type: Review

References (67)

1. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2014: 15(Suppl. 20): 4-17.
2. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014: 383: 69-82.
3. Tran F, Stone M, Huang CY et al. Population-based incidence of diabetes in Australian youth aged 10-18 yr: increase in type 1 diabetes but not type 2 diabetes. Pediatr Diabetes 2014: 15: 585-590.
4. Todd JA. Etiology of type 1 diabetes. Immunity 2010: 32: 457-467.
5. Malaisse WJ, Maedler K. Imaging of the β-cells of the islets of Langerhans. Diabetes Res Clin Pract 2012: 98: 11-18.
6. Imagawa A, Hanafusa T, Tamura S et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001: 50: 1269-1273.
7. Krogvold L, Edwin B, Buanes T et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia 2014: 57: 841-843.
8. Campbell-Thompson M, Wasserfall C, Kaddis J et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 2012: 28: 608-617.
9. Gianani R, Putnam A, Still T et al. Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 2006: 91: 1855-1861.
10. In't Veld P, Lievens D, De Grijse J et al. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 2007: 56: 2400-2404.
11. Tauriainen S, Salmela K, Rantala I, Knip M, Hyöty H. Collecting high-quality pancreatic tissue for experimental study from organ donors with signs of β-cell autoimmunity. Diabetes Metab Res Rev 2010: 26: 585-592.
12. Pugliese A, Yang M, Kusmarteva I et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes 2014: 15: 1-9.
13. Pugliese A, Vendrame F, Reijonen H, Atkinson MA, Campbell-Thompson M, Burke GW. New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation. Curr Diab Rep 2014: 14: 530.
14. Maniatis AK, Yu L, Miao D, Nelson K, Eisenbarth GS. Rapid assays for detection of anti-islet autoantibodies: implications for organ donor screening. J Autoimmun 2001: 16: 71-76.
15. Diamantopoulos S, Allende G, Ferreira J, Ciancio G, Burke G, Pugliese A. Retrospective assessment of islet cell autoantibodies in pancreas organ donors. Diabetes Care 2008: 31: 1741-1742.
16. Winter WE, Harris N, Schatz D. Type 1 diabetes islet autoantibody markers. Diabetes Technol Ther 2002: 4: 817-839.
17. Campbell-Thompson ML, Heiple T, Montgomery E, Zhang L, Schneider L. Staining protocols for human pancreatic islets. J Vis Exp 2012: 63: 4068.
18. Bommer G, Friedl U, Heitz PU, Klöppel G. Pancreatic PP cell distribution and hyperplasia. Immunocytochemical morphology in the normal human pancreas, in chronic pancreatitis and pancreatic carcinoma. Virchows Arch A Pathol Anat Histol 1980: 387: 319-331.
19. Uchida T, Takada T, Ammori BJ, Suda K, Takahashi T. Three-dimensional reconstruction of the ventral and dorsal pancreas: a new insight into anatomy and embryonic development. J Hepatobiliary Pancreat Surg 1999: 6: 176-180.
20. Noble JA, Erlich HA. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med 2012: 2: a007732.
21. Stamm BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol 1984: 15: 677-683.
22. Rudloff U, Bhanot U, Gerald W et al. Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality. Ann Surg Oncol 2010: 17: 2229-2236.
23. Rech TH, Crispim D, Rheinheimer J et al. Brain death-induced inflammatory activity in human pancreatic tissue: a case-control study. Transplantation 2014: 97: 212-219.
24. In't Veld P, De Munck N, Van Belle K et al. Beta-cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 2010: 59: 1702-1708.
25. Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 2014: 38: 476-481.
26. Campbell-Thompson ML, Atkinson MA, Butler AE et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia 2013: 56: 2541-2543.
27. In't Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011: 3: 131-138.
28. Oram RA, McDonald TJ, Shields BM et al. Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diabetes Care 2014: 38:323-328.
29. Davis AK, DuBose SN, Haller MJ et al. Prevalence of detectable C-peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care 2014: 38: 476-481.
30. Liu EH, Digon BJ, Hirshberg B et al. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia 2009: 52: 1369-1380.
31. Keenan HA, Sun JK, Levine J et al. Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010: 59: 2846-2853.
32. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965: 14: 619-633.
33. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986: 29: 267-274.
34. Kloppel G, Clemens A. Insulin-dependent diabetes mellitus: islet changes in relation to etiology and pathogenesis. Endocr Pathol 1997: 8: 273-282.
35. Battaglia M, Atkinson MA. The streetlight effect in type 1 diabetes. Diabetes 2015: 64: 1081-1090.
36. Gianani R, Campbell-Thompson M, Sarkar SA et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 2010: 53: 690-698.
37. Coppieters KT, Dotta F, Amirian N et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012: 209: 51-60.
38. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011: 39: D913-D919.
39. Pipeleers D, In't Veld P, Pipeleers-Marichal M, Gorus F. The beta cell population in type 1 diabetes. Novartis Found Symp 2008: 292: 19-24: discussion 24-31, 122-129, 202-203.
40. Löhr M, Klöppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 1987: 30: 757-762.
41. Gregg BE, Moore PC, Demozay D et al. Formation of a human β-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab 2012: 97: 3197-3206.
42. Kilimnik G, Jo J, Periwal V, Zielinski MC, Hara M. Quantification of islet size and architecture. Islets 2012: 4: 167-172.
43. Brissova M, Fowler MJ, Nicholson WE et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 2005: 53: 1087-1097.
44. Ehrie MG, Swartz FJ. Diploid, tetraploid and octaploid beta cells in the islets of Langerhans of the normal human pancreas. Diabetes 1974: 23: 583-588.
45. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 2007: 50: 2323-2331.
46. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 2010: 53: 2020-2028.
47. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985: 313: 353-360.
48. Foulis AK, Farquharson MA. Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus. Diabetes 1986: 35: 1215-1224.
49. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009: 52: 1143-1151.
50. Bonner-Weir S. Beta-cell turnover: its assessment and implications. Diabetes 2001: 50(Suppl. 1): S20-S24.
51. Henquin JC, Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 2011: 54: 1720-1725.
52. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 2013: 36: 111-117.
53. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983: 24: 366-371.
54. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008: 10(Suppl. 4): 32-42.
55. Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JS. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. JAMA 2012: 308: 2337-2339.
56. Kin T, Murdoch TB, Shapiro AM, Lakey JR. Estimation of pancreas weight from donor variables. Cell Transplant 2006: 15: 181-185.
57. MacLean N, Ogilvie RF. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 1955: 4: 367-376.
58. Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 1984: 26: 456-461.
59. Williams AJ, Thrower SL, Sequeiros IM et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab 2012: 62: 2595-2604.
60. Gaglia JL, Guimaraes AR, Harisinghani M et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011: 121: 442-445.
61. Rowe P, Wasserfall C, Croker B et al. Increased complement activation in human type 1 diabetes pancreata. Diabetes Care 2013: 36: 3815-3817.
62. Sarkar SA, Lee CE, Victorino F et al. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 2012: 61: 436-446.
63. Reddy S, Zeng N, Al-Diery H. Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia 2015: 58: 1024-1035.
64. Piran R, Lee SH, Li CR, Charbono A, Bradley LM, Levine F. Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes. Cell Death Dis 2014: 5: e1357.
65. Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013: 58: 1024-1035.
66. Marhfour I, Lopez XM, Lefkaditis D et al. Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 2012: 55: 2417-2420.
67. Morgan NG, Richardson SJ. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol Metab 2014: 25: 611-619.